Farther Finance Advisors’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.73K Hold
283
– – ﹤0.01% 4702
2026
Q2
$10.7K Hold
283
– – ﹤0.01% 4381
2026
Q1
$11.5K Buy
283
+4
+1% +$145 ﹤0.01% 4012
2025
Q4
$11.2K Buy
+279
New +$7.77K ﹤0.01% 3836

Other funds holding VTVT

Farther Finance Advisors's VTVT Position: Q3 2026 in Review

Farther Finance Advisors held its vTv Therapeutics (VTVT) position steady in Q3 2026 at 283 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4702.

Farther Finance Advisors first reported a position in VTVT in Q4 2025 and has held it in 4 quarters since. The position peaked at $11.5K in Q1 2026. 2 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.

  • Farther Finance Advisors held 283 shares of vTv Therapeutics worth $8.73K as of Q3 2026.
  • Farther Finance Advisors left its vTv Therapeutics share count unchanged in Q3 2026.
  • vTv Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4702 holding.
  • Farther Finance Advisors first reported a position in vTv Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's vTv Therapeutics position peaked at $11.5K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.